FN2 Earnings Intelligence

TG Therapeutics, Inc. cash flow (quarterly)

TG Therapeutics, Inc. (TGTX) Cash Flow (quarterly) derived from persisted SEC financial facts.

Cash Flow

USD in millions, except per-share values and percentages.

Metric 3/31/20256/30/20259/30/20253/31/20269/30/2026
Operating Cash Flow -$28.7---$17.9-
Capital Expenditure $0--$0.1-
Free Cash Flow -$28.7---$17.9-

Get the TGTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.